Clinical Trial Update: Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating nasal CPAP therapy to treat refractory excessive daytime sleepiness in adults with obstructive sleep apnea/hypopnea syndrome; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Nasal CPAP therapy

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Sleep Apnea, Obstructive, Hypopnea Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2011-02-23